{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:04:36Z","timestamp":1793325876268,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Cultivation and Innovation Fund of Huizhou First Hospital","award":["2024QN001"],"award-info":[{"award-number":["2024QN001"]}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515140039"],"award-info":[{"award-number":["2023A1515140039"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Huizhou Science and Technology Research and Development Program","award":["2024CZ010001"],"award-info":[{"award-number":["2024CZ010001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-025-01967-7","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T06:41:09Z","timestamp":1756795269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Machine learning analysis reveals tumor heterogeneity and stromal-immune niches in breast cancer"],"prefix":"10.1038","volume":"8","author":[{"given":"Junjie","family":"Kuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yundong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"1967_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"1967_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer Statist. CA Cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"1967_CR3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3390\/biom9090476","volume":"9","author":"CJ Li","year":"2019","unstructured":"Li, C. J. et al. The molecular mechanism of epithelial-mesenc hymal transition for breast carcinogenesis. Biomolecules 9, 476 (2019).","journal-title":"Biomolecules"},{"key":"1967_CR4","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1111\/jcmm.17436","volume":"26","author":"YT Tzeng","year":"2022","unstructured":"Tzeng, Y. T., et al. Integrated analysis of pivotal biomarker of LSM1, immune cell infiltration and therapeutic drugs in breast cancer. J. Cell Mol. Med. 26, 4007\u20134020 (2022).","journal-title":"J. Cell Mol. Med."},{"key":"1967_CR5","doi-asserted-by":"publisher","first-page":"102527","DOI":"10.1016\/j.ctrv.2023.102527","volume":"115","author":"V M\u00fcller","year":"2023","unstructured":"M\u00fcller, V. et al. Epidemiology, clinical outcomes, and unmet needs of patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases: a systematic literature review. Cancer Treat. Rev. 115, 102527 (2023).","journal-title":"Cancer Treat. Rev."},{"key":"1967_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11912-023-01377-6","volume":"25","author":"O Gluz","year":"2023","unstructured":"Gluz, O. & Graeser, M. Molecular profiling in Early ER\u2009+\u2009breast cancer to aid systemic therapy decisions. Curr. Oncol. Rep. 25, 491\u2013500 (2023).","journal-title":"Curr. Oncol. Rep."},{"key":"1967_CR7","doi-asserted-by":"publisher","first-page":"115803","DOI":"10.1016\/j.bcp.2023.115803","volume":"217","author":"YT Tzeng","year":"2023","unstructured":"Tzeng, Y. T. et al. Breast cancer organoids derived from patients: a platform for tailored drug screening. Biochem Pharm. 217, 115803 (2023).","journal-title":"Biochem Pharm."},{"key":"1967_CR8","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","volume":"28","author":"ME Hammond","year":"2010","unstructured":"Hammond, M. E. et al. American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J. Clin. Oncol. 28, 2784\u20132795 (2010).","journal-title":"J. Clin. Oncol."},{"key":"1967_CR9","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/jnci\/djaa201","volume":"113","author":"TO Nielsen","year":"2021","unstructured":"Nielsen, T. O. et al. Assessment of Ki67 in breast cancer: updated recommendations from the International Ki67 in Breast Cancer Working Group. J. Natl. Cancer Inst. 113, 808\u2013819 (2021).","journal-title":"J. Natl. Cancer Inst."},{"key":"1967_CR10","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMoa1602253","volume":"375","author":"F Cardoso","year":"2016","unstructured":"Cardoso, F. et al. 70-gene signature as an aid to treatment decisions in early-stage breast cancer. N. Engl. J. Med. 375, 717\u2013729 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1967_CR11","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3390\/cells10030648","volume":"10","author":"Y Qian","year":"2021","unstructured":"Qian, Y. et al. Prognostic cancer gene expression signatures: current status and challenges. Cells 10, 648 (2021).","journal-title":"Cells"},{"key":"1967_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1148-6","volume":"21","author":"P J\u00e9z\u00e9quel","year":"2019","unstructured":"J\u00e9z\u00e9quel, P. et al. Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications. Breast Cancer Res. 21, 65 (2019).","journal-title":"Breast Cancer Res."},{"key":"1967_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrc1256","volume":"4","author":"JW Pollard","year":"2004","unstructured":"Pollard, J. W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4, 71\u201378 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"1967_CR14","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3390\/cancers11081205","volume":"11","author":"V Barriga","year":"2019","unstructured":"Barriga, V. et al. The complex interaction between the tumor micro-environment and immune checkpoints in breast cancer. Cancers 11, 1205 (2019).","journal-title":"Cancers"},{"key":"1967_CR15","doi-asserted-by":"publisher","first-page":"8896","DOI":"10.1158\/0008-5472.CAN-05-1734","volume":"65","author":"MM Queen","year":"2005","unstructured":"Queen, M. M. et al. Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression. Cancer Res. 65, 8896\u20138904 (2005).","journal-title":"Cancer Res."},{"key":"1967_CR16","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/imr.12444","volume":"273","author":"LW Treffers","year":"2016","unstructured":"Treffers, L. W. et al. Neutrophils in cancer. Immunol. Rev. 273, 312\u2013328 (2016).","journal-title":"Immunol. Rev."},{"key":"1967_CR17","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/biom10040543","volume":"10","author":"L Gelsomino","year":"2020","unstructured":"Gelsomino, L. et al. Leptin signaling contributes to aromatase inhibitor resistant breast cancer cell growth and activation of macrophages. Biomolecules 10, 543 (2020).","journal-title":"Biomolecules"},{"key":"1967_CR18","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1158\/0008-5472.CAN-14-3587","volume":"75","author":"R Hughes","year":"2015","unstructured":"Hughes, R. et al. Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy. Cancer Res. 75, 3479\u20133491 (2015).","journal-title":"Cancer Res."},{"key":"1967_CR19","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.3390\/ijms25084314","volume":"25","author":"JC de Vicente","year":"2024","unstructured":"de Vicente, J. C. et al. Lectin-like transcript-1 (LLT1) expression in oral squamous cell carcinomas: prognostic significance and relationship with the tumor immune microenvironment. Int. J. Mol. Sci. 25, 4314 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1967_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-024-01325-4","volume":"16","author":"S Lin","year":"2024","unstructured":"Lin, S. et al. Single-cell transcriptomics reveal distinct immune-infiltrating phenotypes and macrophage-tumor interaction axes among different lineages of pituitary neuroendocrine tumors. Genome Med. 16, 60 (2024).","journal-title":"Genome Med."},{"key":"1967_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12929-022-00893-0","volume":"30","author":"FM Tien","year":"2023","unstructured":"Tien, F. M. et al. Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities. J. Biomed. Sci. 30, 3 (2023).","journal-title":"J. Biomed. Sci."},{"key":"1967_CR22","doi-asserted-by":"publisher","first-page":"1325615","DOI":"10.3389\/fimmu.2023.1325615","volume":"14","author":"J Yin","year":"2023","unstructured":"Yin, J. et al. Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications. Front. Immunol. 14, 1325615 (2023).","journal-title":"Front. Immunol."},{"key":"1967_CR23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/nrg1726","volume":"6","author":"JC Pearson","year":"2005","unstructured":"Pearson, J. C., Lemons, D. & McGinnis, W. Modulating Hox gene functions during animal body patterning. Nat. Rev. Genet 6, 893\u2013904 (2005).","journal-title":"Nat. Rev. Genet"},{"key":"1967_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2826","volume":"10","author":"N Shah","year":"2010","unstructured":"Shah, N. & Sukumar, S. The Hox genes and their roles in oncogenesis. Nat. Rev. Cancer 10, 361\u2013371 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"1967_CR25","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00109-014-1181-y","volume":"92","author":"S Bhatlekar","year":"2014","unstructured":"Bhatlekar, S., Fields, J. Z. & Boman, B. M. HOX genes and their role in the development of human cancers. J. Mol. Med.92, 811\u2013823 (2014).","journal-title":"J. Mol. Med."},{"key":"1967_CR26","first-page":"2121","volume":"28","author":"K Inamura","year":"2008","unstructured":"Inamura, K. et al. HOXB2, an adverse prognostic indicator for stage I lung adenocarcinomas, promotes invasion by transcriptional regulation of metastasis-related genes in HOP-62 non-small cell lung cancer cells. Anticancer Res. 28, 2121\u20132127 (2008).","journal-title":"Anticancer Res."},{"key":"1967_CR27","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.7314\/APJCP.2015.16.4.1349","volume":"16","author":"A Gonzalez-Herrera","year":"2015","unstructured":"Gonzalez-Herrera, A. et al. Increased expression of HOXB2 and HOXB13 proteins is associated with HPV infection and cervical cancer progression. Asian Pac. J. Cancer Prev. 16, 1349\u20131353 (2015).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"1967_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-0510-8","volume":"18","author":"F Xu","year":"2020","unstructured":"Xu, F. et al. Epigenetic induction of tumor stemness via the lipopolysaccharide-TET3-HOXB2 signaling axis in esophageal squamous cell carcinoma. Cell Commun. Signal 18, 17 (2020).","journal-title":"Cell Commun. Signal"},{"key":"1967_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre, A. & Weinberg, R. A. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol. 20, 69\u201384 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1967_CR30","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.7150\/ijbs.88837","volume":"20","author":"JH Oh","year":"2024","unstructured":"Oh, J. H. et al. The homeoprotein HOXB2 limits triple-negative breast carcinogenesis via extracellular matrix remodeling. Int J. Biol. Sci. 20, 1045\u20131063 (2024).","journal-title":"Int J. Biol. Sci."},{"key":"1967_CR31","first-page":"2256","volume":"24","author":"HY Yu","year":"2020","unstructured":"Yu, H. Y. & Pan, S. S. MiR-202-5p suppressed cell proliferation, migration and invasion in ovarian cancer via regulating HOXB2. Eur. Rev. Med. Pharm. Sci. 24, 2256\u20132263 (2020).","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"1967_CR32","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ygeno.2011.05.011","volume":"98","author":"PJ Boimel","year":"2011","unstructured":"Boimel, P. J., Cruz, C. & Segall, J. E. A functional in vivo screen for regulators of tumor progression identifies HOXB2 as a regulator of tumor growth in breast cancer. Genomics 98, 164\u2013172 (2011).","journal-title":"Genomics"},{"key":"1967_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3389\/fendo.2017.00293","volume":"8","author":"C Bl\u00fccher","year":"2017","unstructured":"Bl\u00fccher, C. & Stadler, S. C. Obesity and breast cancer: current insights on the role of fatty acids and lipid metabolism in promoting breast cancer growth and progression. Front Endocrinol.8, 293 (2017).","journal-title":"Front Endocrinol."},{"key":"1967_CR34","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1158\/0008-5472.CAN-18-2849","volume":"79","author":"Z Madak-Erdogan","year":"2019","unstructured":"Madak-Erdogan, Z. et al. Free fatty acids rewire cancer metabolism in obesity-associated breast cancer via estrogen receptor and mTOR signaling. Cancer Res. 79, 2494\u20132510 (2019).","journal-title":"Cancer Res."},{"key":"1967_CR35","doi-asserted-by":"publisher","first-page":"103628","DOI":"10.1016\/j.drudis.2023.103628","volume":"28","author":"W George Warren","year":"2023","unstructured":"George Warren, W. et al. The emerging role of fatty acid binding protein 5 (FABP5) in cancers. Drug Discov. Today 28, 103628 (2023).","journal-title":"Drug Discov. Today"},{"key":"1967_CR36","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cytogfr.2005.05.004","volume":"16","author":"Q Jiang","year":"2005","unstructured":"Jiang, Q. et al. Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev. 16, 513\u2013533 (2005).","journal-title":"Cytokine Growth Factor Rev."},{"key":"1967_CR37","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1182\/blood-2002-01-0062","volume":"100","author":"M Iwata","year":"2002","unstructured":"Iwata, M. et al. Functional interleukin-7 receptors (IL-7Rs) are expressed by marrow stromal cells: binding of IL-7 increases levels of IL-6 mRNA and secreted protein. Blood 100, 1318\u20131325 (2002).","journal-title":"Blood"},{"key":"1967_CR38","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ejca.2003.10.016","volume":"40","author":"MA Al-Rawi","year":"2004","unstructured":"Al-Rawi, M. A. et al. Aberrant expression of interleukin-7 (IL-7) and its signalling complex in human breast cancer. Eur. J. Cancer 40, 494\u2013502 (2004).","journal-title":"Eur. J. Cancer"},{"key":"1967_CR39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/10408369991239196","volume":"36","author":"R Fernandez-Botran","year":"1999","unstructured":"Fernandez-Botran, R. Soluble cytokine receptors: basic immunology and clinical applications. Crit. Rev. Clin. Lab Sci. 36, 165\u2013224 (1999).","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"1967_CR40","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1517\/14712598.2.6.585","volume":"2","author":"R Fernandez-Botran","year":"2002","unstructured":"Fernandez-Botran, R., Crespo, F. A. & Sun, X. Soluble cytokine receptors in biological therapy. Expert Opin. Biol. Ther. 2, 585\u2013605 (2002).","journal-title":"Expert Opin. Biol. Ther."},{"key":"1967_CR41","doi-asserted-by":"publisher","first-page":"E1761","DOI":"10.1073\/pnas.1222303110","volume":"110","author":"W Lundstr\u00f6m","year":"2013","unstructured":"Lundstr\u00f6m, W. et al. Soluble IL7R\u03b1 potentiates IL-7 bioactivity and promotes autoimmunity. Proc. Natl. Acad. Sci. USA 110, E1761\u2013E1770 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1967_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.5115\/acb.2015.48.1.10","volume":"48","author":"B Lee","year":"2015","unstructured":"Lee, B. & Hong, C. The role of soluble common gamma chain in autoimmune disease. Anat. Cell Biol. 48, 10\u201315 (2015).","journal-title":"Anat. Cell Biol."},{"key":"1967_CR43","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/ng2106","volume":"39","author":"F Lundmark","year":"2007","unstructured":"Lundmark, F. et al. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat. Genet. 39, 1108\u20131113 (2007).","journal-title":"Nat. Genet."},{"key":"1967_CR44","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ng2068","volume":"39","author":"JA Todd","year":"2007","unstructured":"Todd, J. A. et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 39, 857\u2013864 (2007).","journal-title":"Nat. Genet."},{"key":"1967_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.gene.6364436","volume":"9","author":"FC McKay","year":"2008","unstructured":"McKay, F. C. et al. Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis. Genes Immun. 9, 1\u20136 (2008).","journal-title":"Genes Immun."},{"key":"1967_CR46","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.4049\/jimmunol.0903758","volume":"184","author":"AM Crawley","year":"2010","unstructured":"Crawley, A. M., Faucher, S. & Angel, J. B. Soluble IL-7R alpha (sCD127) inhibits IL-7 activity and is increased in HIV infection. J. Immunol. 184, 4679\u20134687 (2010).","journal-title":"J. Immunol."},{"key":"1967_CR47","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3892\/ijo.2014.2290","volume":"44","author":"SL Park","year":"2014","unstructured":"Park, S. L. et al. p27KIP1 is involved in ERK1\/2-mediated MMP-9 expression via the activation of NF-\u03baB binding in the IL-7-induced migration and invasion of 5637 cells. Int J. Oncol. 44, 1349\u20131356 (2014).","journal-title":"Int J. Oncol."},{"key":"1967_CR48","doi-asserted-by":"publisher","first-page":"747324","DOI":"10.3389\/fimmu.2021.747324","volume":"12","author":"D Chen","year":"2021","unstructured":"Chen, D. et al. Interleukin-7 biology and its effects on immune cells: mediator of generation, differentiation, survival, and homeostasis. Front Immunol. 12, 747324 (2021).","journal-title":"Front Immunol."},{"key":"1967_CR49","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1038\/leu.2017.136","volume":"31","author":"C Delgado-Martin","year":"2017","unstructured":"Delgado-Martin, C. et al. JAK\/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias. Leukemia 31, 2568\u20132576 (2017).","journal-title":"Leukemia"},{"key":"1967_CR50","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1182\/bloodadvances.2018021063","volume":"2","author":"D Ribeiro","year":"2018","unstructured":"Ribeiro, D. et al. STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells. Blood Adv. 2, 2199\u20132213 (2018).","journal-title":"Blood Adv."},{"key":"1967_CR51","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1084\/jem.20040789","volume":"200","author":"JT Barata","year":"2004","unstructured":"Barata, J. T. et al. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. J. Exp. Med 200, 659\u2013669 (2004).","journal-title":"J. Exp. Med"},{"key":"1967_CR52","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1158\/2159-8290.CD-17-0538","volume":"7","author":"T Shum","year":"2017","unstructured":"Shum, T. et al. Constitutive signaling from an engineered IL7 receptor promotes durable tumor elimination by tumor-redirected T cells. Cancer Discov. 7, 1238\u20131247 (2017).","journal-title":"Cancer Discov."},{"key":"1967_CR53","doi-asserted-by":"publisher","first-page":"4795171","DOI":"10.1155\/2020\/4795171","volume":"2020","author":"Z Zhao","year":"2020","unstructured":"Zhao, Z. et al. Engineered IL-7 receptor enhances the therapeutic effect of AXL-CAR-T cells on triple-negative breast cancer. Biomed. Res Int 2020, 4795171 (2020).","journal-title":"Biomed. Res Int"},{"key":"1967_CR54","doi-asserted-by":"publisher","first-page":"1684127","DOI":"10.1080\/2162402X.2019.1684127","volume":"9","author":"B Huang","year":"2020","unstructured":"Huang, B. et al. B7-H3 specific T cells with chimeric antigen receptor and decoy PD-1 receptors eradicate established solid human tumors in mouse models. Oncoimmunology 9, 1684127 (2020).","journal-title":"Oncoimmunology"},{"key":"1967_CR55","doi-asserted-by":"publisher","first-page":"8706","DOI":"10.3390\/ijms22168706","volume":"22","author":"KE Noh","year":"2022","unstructured":"Noh, K. E. et al. TGF-\u03b2\/IL-7 Chimeric switch receptor-expressing CAR-T cells inhibit recurrence of CD19-positive B cell lymphoma. Int. J. Mol. Sci. 22, 8706 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1967_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2019.06.001","volume":"64","author":"M Yasunaga","year":"2020","unstructured":"Yasunaga, M. Antibody therapeutics and immunoregulation in cancer and autoimmune disease. Semin Cancer Biol. 64, 1\u201312 (2020).","journal-title":"Semin Cancer Biol."},{"key":"1967_CR57","doi-asserted-by":"publisher","first-page":"12668","DOI":"10.1073\/pnas.1203692109","volume":"109","author":"C Penaranda","year":"2012","unstructured":"Penaranda, C. et al. IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector\/memory T cells. Proc. Natl. Acad. Sci. USA 109, 12668\u201312673 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1967_CR58","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1002\/art.27578","volume":"62","author":"SA Hartgring","year":"2010","unstructured":"Hartgring, S. A. et al. Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators. Arthritis Rheum. 62, 2716\u20132725 (2010).","journal-title":"Arthritis Rheum."},{"key":"1967_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11255-4","volume":"7","author":"M Yasunaga","year":"2017","unstructured":"Yasunaga, M., Manabe, S. & Matsumura, Y. Immunoregulation by IL-7R-targeting antibody-drug conjugates: overcoming steroid-resistance in cancer and autoimmune disease. Sci. Rep. 7, 10735 (2017).","journal-title":"Sci. Rep."},{"key":"1967_CR60","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1038\/s41375-019-0434-8","volume":"33","author":"P Akkapeddi","year":"2019","unstructured":"Akkapeddi, P. et al. A fully human anti-IL-7R\u03b1 antibody promotes antitumor activity against T-cell acute lymphoblastic leukemia. Leukemia 33, 2155\u20132168 (2019).","journal-title":"Leukemia"},{"key":"1967_CR61","doi-asserted-by":"publisher","first-page":"22605","DOI":"10.18632\/oncotarget.25194","volume":"9","author":"E Senkevitch","year":"2018","unstructured":"Senkevitch, E. et al. Inhibiting Janus Kinase 1 and BCL-2 to treat T cell acute lymphoblastic leukemia with IL7-R\u03b1 mutations. Oncotarget 9, 22605\u201322617 (2018).","journal-title":"Oncotarget"},{"key":"1967_CR62","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1182\/blood-2012-03-415448","volume":"120","author":"SL Maude","year":"2012","unstructured":"Maude, S. L. et al. Targeting JAK1\/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia. Blood 120, 3510\u20133518 (2012).","journal-title":"Blood"},{"key":"1967_CR63","doi-asserted-by":"publisher","first-page":"5929","DOI":"10.1016\/S0021-9258(18)53409-8","volume":"268","author":"Y Oda","year":"1993","unstructured":"Oda, Y. et al. Soluble lactose-binding lectin from rat intestine with two different carbohydrate-binding domains in the same peptide chain. J. Biol. Chem. 268, 5929\u20135939 (1993).","journal-title":"J. Biol. Chem."},{"key":"1967_CR64","doi-asserted-by":"publisher","first-page":"20807","DOI":"10.1016\/S0021-9258(17)31891-4","volume":"269","author":"SH Barondes","year":"1994","unstructured":"Barondes, S. H. et al. Galectins. Structure and function of a large family of animal lectins. J. Biol. Chem. 269, 20807\u201320810 (1994).","journal-title":"J. Biol. Chem."},{"key":"1967_CR65","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.3389\/fimmu.2019.01594","volume":"10","author":"IM Yasinska","year":"2019","unstructured":"Yasinska, I. M. et al. The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer. Front. Immunol. 10, 1594 (2019).","journal-title":"Front. Immunol."},{"key":"1967_CR66","doi-asserted-by":"publisher","first-page":"e21401","DOI":"10.1096\/fj.202000528RR","volume":"35","author":"Z Chen","year":"2021","unstructured":"Chen, Z. et al. The role of Tim-3\/Galectin-9 pathway in T-cell function and prognosis of patients with human papilloma virus-associated cervical carcinoma. Faseb J.35, e21401 (2021).","journal-title":"Faseb J."},{"key":"1967_CR67","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1038\/s41388-020-1186-7","volume":"39","author":"AM Seifert","year":"2020","unstructured":"Seifert, A. M. et al. Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels. Oncogene 39, 3102\u20133113 (2020).","journal-title":"Oncogene"},{"key":"1967_CR68","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1002\/jcp.29309","volume":"235","author":"F Yuan","year":"2020","unstructured":"Yuan, F. et al. Molecular and clinical characterization of Galectin-9 in glioma through 1027 samples. J. Cell Physiol. 235, 4326\u20134334 (2020).","journal-title":"J. Cell Physiol."},{"key":"1967_CR69","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jdermsci.2019.09.004","volume":"96","author":"R Nakajima","year":"2019","unstructured":"Nakajima, R. et al. Possible therapeutic applicability of galectin-9 in cutaneous T-cell lymphoma. J. Dermatol Sci. 96, 134\u2013142 (2019).","journal-title":"J. Dermatol Sci."},{"key":"1967_CR70","first-page":"1019","volume":"17","author":"K Wdowiak","year":"2019","unstructured":"Wdowiak, K. et al. Increased serum levels of Galectin-9 in patients with chronic lymphocytic leukemia. Oncol. Lett. 17, 1019\u20131029 (2019).","journal-title":"Oncol. Lett."},{"key":"1967_CR71","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.immuni.2014.06.011","volume":"41","author":"C Wu","year":"2014","unstructured":"Wu, C. et al. Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells. Immunity 41, 270\u2013282 (2014).","journal-title":"Immunity"},{"key":"1967_CR72","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1158\/1078-0432.CCR-04-0861","volume":"11","author":"A Irie","year":"2005","unstructured":"Irie, A. et al. Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer. Clin. Cancer Res. 11, 2962\u20132968 (2005).","journal-title":"Clin. Cancer Res."},{"key":"1967_CR73","doi-asserted-by":"publisher","first-page":"S196","DOI":"10.1111\/j.1075-122X.2006.00334.x","volume":"12","author":"A Yamauchi","year":"2006","unstructured":"Yamauchi, A. et al. Galectin-9, a novel prognostic factor with antimetastatic potential in breast cancer. Breast J. 12, S196\u2013S200 (2006).","journal-title":"Breast J."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01967-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01967-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01967-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:27:24Z","timestamp":1756898844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01967-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1967"],"URL":"https:\/\/doi.org\/10.1038\/s41746-025-01967-7","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"21 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"565"}}